gene,cancer,cancer_long_name,mutation_type,mutation,ESCAT,transcript_exon,info,tissue,official,reference,DOI
EGFR,NSCLC,non-squamous non-small-cell lung cancer,SNP,L858R,IA,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.014
EGFR,NSCLC,non-squamous non-small-cell lung cancer,DEL,deletion,IA,19,deletion in exon 19,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.015
EGFR,NSCLC,non-squamous non-small-cell lung cancer,SNP,T790M,IA,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.016
EGFR,NSCLC,non-squamous non-small-cell lung cancer,SNP,G719X,IB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.017
EGFR,NSCLC,non-squamous non-small-cell lung cancer,SNP,L861Q,IB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.018
EGFR,NSCLC,non-squamous non-small-cell lung cancer,SNP,S768I,IB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.019
EGFR,NSCLC,non-squamous non-small-cell lung cancer,INS,insertion,IA,20,insertion in exon 20,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.020
ALK,NSCLC,non-squamous non-small-cell lung cancer,FUS,fusion,IA,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.021
MET,NSCLC,non-squamous non-small-cell lung cancer,SNP,mutation,IB,14,mutations in exon 14,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.022
MET,NSCLC,non-squamous non-small-cell lung cancer,CNV,amplification,IIB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.023
BRAF,NSCLC,non-squamous non-small-cell lung cancer,SNP,V600E,IB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.024
ROS1,NSCLC,non-squamous non-small-cell lung cancer,FUS,fusion,IB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.025
NTRK,NSCLC,non-squamous non-small-cell lung cancer,FUS,fusion,IC,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.026
RET,NSCLC,non-squamous non-small-cell lung cancer,FUS,fusion,IC,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.027
KRAS,NSCLC,non-squamous non-small-cell lung cancer,SNP,G12C,IIB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.028
ERBB2,NSCLC,non-squamous non-small-cell lung cancer,SNP,mutation,IIB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.029
ERBB2,NSCLC,non-squamous non-small-cell lung cancer,CNV,amplification,IIB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.030
BRCA1,NSCLC,non-squamous non-small-cell lung cancer,SNP,mutation,IIIA,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.031
BRCA2,NSCLC,non-squamous non-small-cell lung cancer,SNP,mutation,IIIA,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.032
PIK3CA,NSCLC,non-squamous non-small-cell lung cancer,SNP,mutation,IIIA,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.033
NRG1,NSCLC,non-squamous non-small-cell lung cancer,FUS,fusion,IIIB,,,Lung,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.034
ERBB2,mBC,metastatic breast cancer,CNV,amplification,IA,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.035
ERBB2,mBC,metastatic breast cancer,SNP,mutation,IIB,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.036
PIK3CA,mBC,metastatic breast cancer,SNP,mutation,IA,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.037
BRCA1,mBC,metastatic breast cancer,SNP,mutation,IIIA,,somatic,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.038
BRCA2,mBC,metastatic breast cancer,SNP,mutation,IIIA,,somatic,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.039
BRCA1,mBC,metastatic breast cancer,SNP,mutation,IA,,germline,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.040
BRCA2,mBC,metastatic breast cancer,SNP,mutation,IA,,germline,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.041
PALB2,mBC,metastatic breast cancer,SNP,mutation,IIA,,germline,Breast,yes,Gennari A et al. Annal Oncol 2021; 32(12):1475-1495,https://doi.org/10.1016/j.annonc.2020.07.042
,mBC,metastatic breast cancer,MSI-H,microsatellite_instability,IC,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.043
,mBC,metastatic breast cancer,MSI-H,microsatellite_instability,IC,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.044
NTRK,mBC,metastatic breast cancer,FUS,fusion,IC,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.045
ESR1,mBC,metastatic breast cancer,SNP,mutation,IIA,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.046
PTEN,mBC,metastatic breast cancer,SNP,mutation,IIA,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.047
AKT1,mBC,metastatic breast cancer,SNP,E17K,IIB,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.048
MDM2,mBC,metastatic breast cancer,CNV,amplification,IIIA,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.049
ERBB3,mBC,metastatic breast cancer,SNP,mutation,IIIB,,,Breast,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.050
BRAF,mCRC,metastatic colorectal cancer,SNP,V600E,IA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.051
,mCRC,metastatic colorectal cancer,MSI-H,microsatellite_instability,IA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.052
NTRK1,mCRC,metastatic colorectal cancer,FUS,fusion,IC,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.053
ERBB2,mCRC,metastatic colorectal cancer,CNV,amplification,IIB,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.054
PIK3CA,mCRC,metastatic colorectal cancer,SNP,mutation,IIIA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.055
ATM,mCRC,metastatic colorectal cancer,SNP,mutation,IIIA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.056
MET,mCRC,metastatic colorectal cancer,CNV,amplification,IIIA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.057
AKT1,mCRC,metastatic colorectal cancer,SNP,E17K,IIIA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.058
RET,mCRC,metastatic colorectal cancer,FUS,fusion,IIIA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.059
ALK,mCRC,metastatic colorectal cancer,FUS,fusion,IIIA,,,Colorectal,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.060
BRCA1,PC,Prostate cancer,SNP,mutation,IA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.061
BRCA2,PC,Prostate cancer,SNP,mutation,IA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.062
BRCA1,PC,Prostate cancer,DEL,deletion,IA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.063
BRCA2,PC,Prostate cancer,DEL,deletion,IA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.064
,PC,Prostate cancer,MSI-H,microsatellite_instability,IC,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.065
PTEN,PC,Prostate cancer,SNP,mutation,IIA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.066
PTEN,PC,Prostate cancer,DEL,deletion,IIA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.067
ATM,PC,Prostate cancer,SNP,mutation,IIA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.068
ATM,PC,Prostate cancer,DEL,deletion,IIA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.069
PALB2,PC,Prostate cancer,SNP,mutation,IIB,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.070
PIK3CA,PC,Prostate cancer,SNP,mutation,IIIA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.071
AKT1,PC,Prostate cancer,SNP,E17K,IIIA,,,Prostate,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.072
ERBB2,mGC,metastatic gastric cancer,CNV,amplification,IA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.073
ERBB2,mGC,metastatic gastric cancer,SNP,mutation,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.074
,mGC,metastatic gastric cancer,MSI-H,microsatellite_instability,IC,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.075
NTRK,mGC,metastatic gastric cancer,FUS,fusion,IC,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.076
EGFR,mGC,metastatic gastric cancer,CNV,amplification,IIB,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.077
MET,mGC,metastatic gastric cancer,CNV,amplification,IIB,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.078
MET,mGC,metastatic gastric cancer,SNP,mutation,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.079
PIK3CA,mGC,metastatic gastric cancer,SNP,mutation,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.080
FGFR2,mGC,metastatic gastric cancer,CNV,amplification,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.081
ATM,mGC,metastatic gastric cancer,SNP,mutation,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.082
BRCA1,mGC,metastatic gastric cancer,SNP,mutation,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.083
BRCA2,mGC,metastatic gastric cancer,SNP,mutation,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.084
ROS1,mGC,metastatic gastric cancer,FUS,fusion,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.085
RET,mGC,metastatic gastric cancer,FUS,fusion,IIIA,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.086
ERBB3,mGC,metastatic gastric cancer,SNP,mutation,IIIB,,,Stomach,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.087
BRCA1,PDAC,pancreatic ductal adenocarcinoma,SNP,mutation,IIIB,,somatic,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.088
BRCA2,PDAC,pancreatic ductal adenocarcinoma,SNP,mutation,IIIB,,somatic,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.089
BRCA1,PDAC,pancreatic ductal adenocarcinoma,SNP,mutation,IA,,germline,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.090
BRCA2,PDAC,pancreatic ductal adenocarcinoma,SNP,mutation,IA,,germline,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.091
,PDAC,pancreatic ductal adenocarcinoma,MSI-H,microsatellite_instability,IC,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.092
NTRK,PDAC,pancreatic ductal adenocarcinoma,FUS,fusion,IC,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.093
KRAS,PDAC,pancreatic ductal adenocarcinoma,SNP,mutation,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.094
PIK3CA,PDAC,pancreatic ductal adenocarcinoma,SNP,mutation,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.095
BRAF,PDAC,pancreatic ductal adenocarcinoma,SNP,V600E,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.096
MDM2,PDAC,pancreatic ductal adenocarcinoma,CNV,amplification,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.097
ERBB2,PDAC,pancreatic ductal adenocarcinoma,CNV,amplification,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.098
ERBB2,PDAC,pancreatic ductal adenocarcinoma,SNP,mutation,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.099
NRG1,PDAC,pancreatic ductal adenocarcinoma,FUS,fusion,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.100
ALK,PDAC,pancreatic ductal adenocarcinoma,FUS,fusion,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.101
RET,PDAC,pancreatic ductal adenocarcinoma,FUS,fusion,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.102
ROS1,PDAC,pancreatic ductal adenocarcinoma,FUS,fusion,IIIA,,,Pancreas,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.103
NTRK,HCC,hepatocellular carcinoma,FUS,fusion,IC,,,Liver,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.104
,HCC,hepatocellular carcinoma,MSI-H,microsatellite_instability,IC,,,Liver,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.105
PIK3CA,HCC,hepatocellular carcinoma,SNP,mutation,IIIA,,,Liver,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.106
MET,HCC,hepatocellular carcinoma,CNV,amplification,IIIA,,,Liver,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.107
RAS,HCC,hepatocellular carcinoma,SNP,mutation,IIIA,,,Liver,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.108
IDH1,CC,cholangiocarcinoma,SNP,mutation,IA,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.109
FGFR2,CC,cholangiocarcinoma,FUS,fusion,IB,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.110
,CC,cholangiocarcinoma,MSI-H,microsatellite_instability,IC,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.111
NTRK,CC,cholangiocarcinoma,FUS,fusion,IC,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.112
BRAF,CC,cholangiocarcinoma,SNP,V600E,IIB,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.113
ERBB2,CC,cholangiocarcinoma,CNV,amplification,IIIA,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.114
ERBB2,CC,cholangiocarcinoma,SNP,mutation,IIIA,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.115
PIK3CA,CC,cholangiocarcinoma,SNP,mutation,IIIA,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.116
BRCA1,CC,cholangiocarcinoma,SNP,mutation,IIIA,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.117
BRCA2,CC,cholangiocarcinoma,SNP,mutation,IIIA,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.118
MET,CC,cholangiocarcinoma,CNV,amplification,IIIA,,,Bile_Duct,yes,Mosele F et al. Annal Oncol 2020; 31(11):1491-1505,https://doi.org/10.1016/j.annonc.2020.07.119
PIK3CA,HNSCC,head and neck squamous cell carcinoma,SNP,E542K,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.280
PIK3CA,HNSCC,head and neck squamous cell carcinoma,SNP,E545K,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.281
PIK3CA,HNSCC,head and neck squamous cell carcinoma,SNP,E545A,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.282
PIK3CA,HNSCC,head and neck squamous cell carcinoma,SNP,H1047R,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.283
PIK3CA,HNSCC,head and neck squamous cell carcinoma,SNP,H1047L,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.284
PIK3CA,HNSCC,head and neck squamous cell carcinoma,CNV,amplification,IIIB,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.285
PIK3CA,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,IIIB,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.286
PTEN,HNSCC,head and neck squamous cell carcinoma,CNV,deletion,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.287
PTEN,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.288
HRAS,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,IB,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.289
CDKN2A,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,IIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.290
CDKN2A,HNSCC,head and neck squamous cell carcinoma,CNV,deletion,IIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.291
EGFR,HNSCC,head and neck squamous cell carcinoma,CNV,amplification,IIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.292
ERBB2,HNSCC,head and neck squamous cell carcinoma,CNV,amplification,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.293
FGFR1,HNSCC,head and neck squamous cell carcinoma,CNV,amplification,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.294
FGFR3,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.295
MET,HNSCC,head and neck squamous cell carcinoma,CNV,amplification,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.296
NTRK,HNSCC,head and neck squamous cell carcinoma,FUS,fusion,IC,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.297
TP53,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,V,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.298
BRCA1,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.299
BRCA2,HNSCC,head and neck squamous cell carcinoma,SNP,mutation,IIIA,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.300
,HNSCC,head and neck squamous cell carcinoma,MSI-H,microsatellite_instability,IC,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.301
,HNSCC,head and neck squamous cell carcinoma,TMB-H,TMB,IC,,,Head_and_Neck,yes,Marret G et al. JCO Precision Oncology 2021; 5:215-226,https://doi.org/10.1200/PO.20.302
KIT,GIST,Gastrointestinal stromal tumors,CNV,deletion,IA,11,deletion in exon 11,Soft_Tissue,yes,Casali PG et al. Annal Oncol 2022; 33(1):20-33,https://doi.org/10.1016/j.annonc.2021.09.005
KIT,GIST,Gastrointestinal stromal tumors,SNP,mutation,IA,,,Soft_Tissue,yes,Casali PG et al. Annal Oncol 2022; 33(1):20-33,https://doi.org/10.1016/j.annonc.2021.09.006
PDGFRA,GIST,Gastrointestinal stromal tumors,SNP,D842V,IB,,,Soft_Tissue,yes,Casali PG et al. Annal Oncol 2022; 33(1):20-33,https://doi.org/10.1016/j.annonc.2021.09.007
NTRK,GIST,Gastrointestinal stromal tumors,FUS,fusion,IC,,,Soft_Tissue,yes,Casali PG et al. Annal Oncol 2022; 33(1):20-33,https://doi.org/10.1016/j.annonc.2021.09.008
BRAF,GIST,Gastrointestinal stromal tumors,SNP,mutation,IIIA,,,Soft_Tissue,yes,Casali PG et al. Annal Oncol 2022; 33(1):20-33,https://doi.org/10.1016/j.annonc.2021.09.009
BRAF,TC,Advance thyroid cancer,SNP,mutation,IB,,,Thyroid,yes,Filetti S et al. Annal Oncol 2022; 33(7):674-684,https://doi.org/10.1016/j.annonc.2022.04.009
NTRK,TC,Advance thyroid cancer,FUS,fusion,IC,,,Thyroid,yes,Filetti S et al. Annal Oncol 2022; 33(7):674-684,https://doi.org/10.1016/j.annonc.2022.04.010
RET,TC,Advance thyroid cancer,SNP,mutation,IB,,,Thyroid,yes,Filetti S et al. Annal Oncol 2022; 33(7):674-684,https://doi.org/10.1016/j.annonc.2022.04.011
RET,TC,Advance thyroid cancer,FUS,fusion,IB,,,Thyroid,yes,Filetti S et al. Annal Oncol 2022; 33(7):674-684,https://doi.org/10.1016/j.annonc.2022.04.012
ERBB2,GC,Gastric cancer,CNV,amplification,IA,,,Stomach,yes,In press: Lordick F et al. Annal Oncol 2022,https://doi.org/10.1016/j.annonc.2022.07.004
,GC,Gastric cancer,MSI-H,microsatellite_instability,IB,,,Stomach,yes,In press: Lordick F et al. Annal Oncol 2022,https://doi.org/10.1016/j.annonc.2022.07.004
ERBB2,,Oesophageal cancer,CNV,amplification,IA,,,Esophagus,yes,In press: Obermannova' R et al. Annal Oncol 2022,https://doi.org/10.1016/j.annonc.2022.07.003
,,Oesophageal cancer,MSI-H,microsatellite_instability,IC,,,Esophagus,yes,In press: Obermannova' R et al. Annal Oncol 2022,https://doi.org/10.1016/j.annonc.2022.07.003
PML-RARA,AML,Acute myeloid leukemia,FUS,fusion,IA,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.018
FLT3-ITD,AML,Acute myeloid leukemia,FUS,fusion,IA,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.019
FLT3,AML,Acute myeloid leukemia,SNP,mutation,IA,,in TDK (tyrosin kinase domain),Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.020
RUNX1-RUNX1T1,AML,Acute myeloid leukemia,FUS,fusion,IA,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.021
CBFB-MYH11,AML,Acute myeloid leukemia,FUS,fusion,IA,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.022
ASXL1,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.023
BCOR,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.024
EZH2,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.025
RUNX1,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.026
SF3B1,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.027
SRSF2,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.028
STAG2,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.029
U2AF1,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.030
ZRSR2,AML,Acute myeloid leukemia,SNP,mutation,IA,,AML with myelodysplasia-related gene mutations for treatment with CPX-351,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.031
IDH1,AML,Acute myeloid leukemia,SNP,R132C,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.032
IDH1,AML,Acute myeloid leukemia,SNP,R132H,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.033
IDH1,AML,Acute myeloid leukemia,SNP,R132G,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.034
IDH1,AML,Acute myeloid leukemia,SNP,R132S,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.035
IDH1,AML,Acute myeloid leukemia,SNP,R132L,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.036
IDH2,AML,Acute myeloid leukemia,SNP,R140Q,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.037
IDH2,AML,Acute myeloid leukemia,SNP,R140W,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.038
IDH2,AML,Acute myeloid leukemia,SNP,R140L,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.039
IDH2,AML,Acute myeloid leukemia,SNP,R140G,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.040
IDH2,AML,Acute myeloid leukemia,SNP,V147I,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.041
IDH2,AML,Acute myeloid leukemia,SNP,R172K,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.042
IDH2,AML,Acute myeloid leukemia,SNP,R172W,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.043
IDH2,AML,Acute myeloid leukemia,SNP,R172N,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.044
IDH2,AML,Acute myeloid leukemia,INS,insertion,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.045
IDH2,AML,Acute myeloid leukemia,DEL,deletion,IIIB,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.046
BCR-ABL,AML,Acute myeloid leukemia,FUS,fusion,IIA,,,Bone_Marrow,yes,Heuser M et al. Annal Oncol 2020; 31(6):697-712,https://doi.org/10.1016/j.annonc.2020.02.047
